Barely Significant
← all excerpts

Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients.

Breast Cancer Res Treat · 2020 · PMC7599145 · PMID 32852708

Europe PMCDOI
2
hedged sentences
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

did not achieve significanceP = 0.05actually significant
Distant metastasis-free survival, overall survival, and local recurrence-free survival Breast cancer patients with FGFR1 amplification had a poorer DMFS than patients without amplification ( P = 0.04, unadjusted analysis); however, this difference in DMFS outcome did not achieve significance in the adjusted analysis ( P = 0.05).

also in 1,397 other papers

showed a trendno p-value reported
In this study, BC patients with FGFR1 amplification showed a trend toward poorer outcomes, especially DMFS and LRFS.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.